Lyra Therapeutics, Inc. - LYRA Trailing Twelve Months Revenue Growth

Public company logo of lyratherapeutics.com (LYRA)

Lyra Therapeutics, Inc. (LYRA) is currently restructuring its scientific portfolio to cut costs following failed trials. The LTM sales trend clearly confirms these challenges, where -59.10 shows the current value of the metric. Business success depends on physician adoption of new rhinosinusitis treatment methods. Simultaneously, the company is implementing ESG standards by optimizing laboratory energy consumption and minimizing chemical waste.

LYRA - Lyra Therapeutics Sales Growth YoY (TTM) over the range 02/11/2024 - 03/28/2026

Lyra Therapeutics, Inc. - analytical breakdowns and key metrics (LYRA)

- stock price and consensus target price:
Summary company analytics:Lyra Therapeutics, Inc
Brand item of Lyra Therapeutics Inc

To build a high-quality portfolio, I analyze demand resilience through revenue dynamics. This metric calculates the percentage change in sales volume over the last four quarters compared to the same period last year. For Lyra Therapeutics, Inc. (LYRA), this calculation reflects the commercial implementation of nasal implant patents under strict FDA oversight. The year-over-year sales volume growth trajectory for the TTM allows for an assessment of the effectiveness in overcoming regulatory barriers.

Who Lyra Therapeutics, Inc. competes with

Sales Growth YoY (TTM) Haleon Corp HLN|Kenvue Inc - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth veronapharma.com|Jyong Bio (MENS) - Sales Growth YoY (Last Twelve Months)|Revenue Growth Rate YoY (Last Twelve Months) Ligand LGND|AMRX (amneal.com) - Sales Growth YoY (TTM)|PRGO: Revenue Dynamics YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) ALVO (Alvotech Corp)|Annual Revenue Growth (Last Twelve Months) Liquidia Corporation|Sales Growth YoY (TTM) GLPG (glpg.com)|Revenue Dynamics YoY (Last Twelve Months) ANIP|MNKD - Sales Growth YoY (Last Twelve Months)|Amphastar - Revenue Change YoY (Last 12 Months)|PCRX: Sales Growth YoY (TTM)|ars-pharma.com - Revenue Dynamics YoY (Last Twelve Months)|TBPH (Theravance Biopharma Inc) - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Aquestive Pharma AQST|Sales Growth YoY (TTM) SCPH|Revenue Change YoY (Last 12 Months) TECX|Sales Growth YoY (Last Twelve Months) tonixpharma.com TNXP|SXTC (SXT China) - Trailing Twelve Months Sales Growth|Eupraxia Pharmaceuticals - Sales Growth YoY (TTM)|Annual Revenue Growth (Last Twelve Months) BioHarvest Sciences Inc. BHST|EXOZ: Sales Growth YoY (TTM)|Oramed (ORMP) - Sales Growth YoY (TTM)|ENTX (Entera Bio) - Sales Growth YoY (TTM)|ipatherapeutics.com (HYFT) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) ABVC|CPIX (Cumberland Pharmaceuticals Inc) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Quantum BioPharma Corp QNTM|FibroGen Corporation (FGEN) - Trailing Twelve Months Revenue Growth|TELO: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) Rani Therapeutics Holdings, Inc. RANI|Synergy CHC Corp (SNYR) - Sales Growth YoY (Last Twelve Months)|RLYB - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Lexaria Bioscience|Pulmatrix Corp - Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) ftzy.com.cn (PTHL)|Aptorum Group - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (TTM) IBO (impactbiomedinc.com)|TNFA: Sales Growth YoY (Last 12 Months)|YCBD - Sales Growth YoY (Last Twelve Months)|PRFX - Sales Growth YoY (TTM)|CYTO (altamiratherapeutics.com) - Revenue Growth YoY (Last 12 Months)|LIPO - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) OPTN|Pieris Pharmaceuticals Inc (PIRS) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) PROC|PTPI: Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) Qilian International QLI|Revenue Change YoY (Last 12 Months) SLRN (Acelyrin, Inc.)|TFFP - Sales Growth YoY (Last Twelve Months)